All of the tested variables, i.e. overweight/obesity, stage, features of the primary tumor, estrogen and progesterone receptor expression, L1CAM expression, and adjuvant therapy, were associated with cancer-related mortality in unadjusted analyses. This evidence concerns the gene PGR and obesity due to melanocortin 4 receptor deficiency.